P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

NCT03077243 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell
Head and Neck Neoplasms
Oropharyngeal Neoplasms

Interventions

RADIATION: Intensity Modulated Radiotherapy (IMRT)
DRUG: Cisplatin (or alternative)
PROCEDURE: Assessment for surgical evaluation

Sponsor

UNC Lineberger Comprehensive Cancer Center